Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 800 of 2051 entries
View as:

Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00227435 Org: User:
Start: 02/28/03 End: 07/31/04 Due: 07/31/05

A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00131404 Org: User:
Start: 09/30/05 End: 12/31/08 Due: 12/31/09

A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004)

Phase: N/A Priority: Normal
NCT ID: NCT02461563 Org: User:
Start: 06/23/15 End: 12/23/15 Due: 12/23/16

A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)

Phase: N/A Priority: Normal
NCT ID: NCT00990821 Org: User:
Start: 01/31/05 End: 01/31/06 Due: 01/31/07

A Study of the Effect of Itraconazole and Phenytoin on MK-1084 in Healthy Adults (MK-1084-008)

Phase: N/A Priority: Normal
NCT ID: NCT06719557 Org: User:
Start: 05/20/24 End: 07/30/24 Due: 07/30/25

Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)

Phase: N/A Priority: Normal
NCT ID: NCT05115838 Org: User:
Start: 01/04/24 End: 10/02/25 Due: 10/02/26

Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)

Phase: N/A Priority: Normal
NCT ID: NCT00424554 Org: User:
Start: 09/26/06 End: 02/16/11 Due: 02/16/12

Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019)

Phase: N/A Priority: Normal
NCT ID: NCT01006616 Org: User:
Start: 10/01/09 End: 11/01/11 Due: 11/01/12

Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)

Phase: N/A Priority: Normal
NCT ID: NCT00966030 Org: User:
Start: 03/31/08 End: 05/31/08 Due: 05/31/09

A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00157898 Org: User:
Start: 01/31/04 End: 09/30/04 Due: 09/30/05

Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00725543 Org: User:
Start: 06/30/04 End: 06/30/10 Due: 06/30/11

The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009)

Phase: N/A Priority: Normal
NCT ID: NCT01797536 Org: User:
Start: 03/06/13 End: 08/20/14 Due: 08/20/15

A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)

Phase: N/A Priority: Normal
NCT ID: NCT00482079 Org: User:
Start: 05/13/03 End: 06/15/06 Due: 06/15/07

A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822)

Phase: N/A Priority: Normal
NCT ID: NCT00863525 Org: User:
Start: 11/30/04 End: 06/30/06 Due: 06/30/07

An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00384605 Org: User:
Start: 10/31/06 End: 12/31/08 Due: 12/31/09

A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)

Phase: N/A Priority: Normal
NCT ID: NCT00414050 Org: User:
Start: 10/06/06 End: 10/24/07 Due: 10/24/08

Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)

Phase: N/A Priority: Normal
NCT ID: NCT01841697 Org: User:
Start: 06/13/13 End: 11/17/14 Due: 11/17/15

Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)

Phase: N/A Priority: Normal
NCT ID: NCT00925015 Org: User:
Start: 06/17/09 End: 12/06/10 Due: 12/06/11

ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)

Phase: N/A Priority: Normal
NCT ID: NCT00856024 Org: User:
Start: 07/31/08 End: 10/31/10 Due: 10/31/11

Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001)

Phase: N/A Priority: Normal
NCT ID: NCT02731742 Org: User:
Start: 06/22/16 End: 01/08/18 Due: 01/08/19

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

Phase: N/A Priority: Normal
NCT ID: NCT01477853 Org: User:
Start: 10/24/11 End: 12/04/12 Due: 12/04/13

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Phase: N/A Priority: Normal
NCT ID: NCT00834106 Org: User:
Start: 12/31/08 End: 09/30/16 Due: 09/30/17

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT00509236 Org: User:
Start: 10/19/07 End: 03/14/11 Due: 03/14/12

MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

Phase: N/A Priority: Normal
NCT ID: NCT00703690 Org: User:
Start: 01/31/02 End: 12/31/03 Due: 12/31/04

A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029)

Phase: N/A Priority: Normal
NCT ID: NCT00127127 Org: User:
Start: 06/10/05 End: 08/21/09 Due: 08/21/10